A multi-scale model to predict outcomes of immunomodulation and drug therapy during tuberculosis Mycobacterium tuberculosis (Mtb) is the most successful pathogen known to humans;it is responsible for ~2 million deaths/year and infects an estimated 1/3 of the world. Despite decades of study, our understanding of the interplay of various pathogen and immune processes that allow for different outcomes in tuberculosis (TB), i.e. primary TB, latency and reactivation TB, remains incomplete. The hallmark of TB is the formation of a spherical collection of immune cells in the lung and lymph node that both immunologically restrains and physically contains the bacteria. Yet bacilli can survive within granuloma for years. Current therapy requires 6 months of treatment with multiple antibiotics;immunomodulation may be able to augment this treatment, shortening treatment time and reducing side effects. There is a crucial need for an in silico platform to provide a cost-effective means of predicting the outcome of new treatment strategies. The long-term goals of this project are to integrate knowledge about immune system dynamics in these organs into a realistic, multi-scale, multi-organ model of the immune response during Mtb infection and to use this model to identify optimal approaches for immunomodulation/antibiotic therapy.
The specific aims are:
Aim 1 : Incorporate new components (IL-10, bacterial population dynamics) into our existing multi-scale lung granuloma model, and use the model to predict factors affecting control of infection in the lung.
Aim 2 : Incorporate new information (lymph node anatomy, key cytokines, and bacterial populations) into our existing multi-scale lymph node model, and use the model to predict factors leading to initiation of the immune response and granuloma formation and maintenance in a lymph node.
Aim 3. Build a multi-compartment, multi-scale model that includes the models of Aims 1 and 2 and trafficking events between the organs, and use this model to predict infection control and pathology at the level of individual granulomas during immunodulation/antibiotic therapy. Data generated herein from non-human primates will inform our models and be used to validate predictions. Our systems biology approach - incorporating both computational and experimental tools - will allow us to predict and test hypotheses regarding key mechanisms that influence immunity to TB. Our interdisciplinary approach will also serve the broader community of researchers investigating areas related to TB, immunity and multi-scale modeling by providing data and tools that will be made readily available.

Public Health Relevance

Using a combined experimental/computational systems biology approach, we will develop a realistic multi-scale multi-compartment model that describes the immune response to infection with the bacteria that causes tuberculosis. The model will be used to predict the outcome of treatment strategies that boost immunity during antibiotic treatment, providing a cost-effective means of evaluating therapeutic interventions.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01EB012579-07
Application #
8657041
Study Section
Modeling and Analysis of Biological Systems Study Section (MABS)
Program Officer
Peng, Grace
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Warsinske, Hayley C; Wheaton, Amanda K; Kim, Kevin K et al. (2016) Computational Modeling Predicts Simultaneous Targeting of Fibroblasts and Epithelial Cells Is Necessary for Treatment of Pulmonary Fibrosis. Front Pharmacol 7:183
Marino, Simeone; Gideon, Hannah P; Gong, Chang et al. (2016) Computational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome. PLoS Comput Biol 12:e1004804
Pienaar, Elsje; Matern, William M; Linderman, Jennifer J et al. (2016) Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions. Infect Immun 84:1650-69
Ziraldo, Cordelia; Gong, Chang; Kirschner, Denise E et al. (2015) Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study. Front Microbiol 6:1477
Linderman, Jennifer J; Kirschner, Denise E (2015) In silico models of M. tuberculosis infection provide a route to new therapies. Drug Discov Today Dis Models 15:37-41
Pienaar, Elsje; Dartois, Véronique; Linderman, Jennifer J et al. (2015) In silico evaluation and exploration of antibiotic tuberculosis treatment regimens. BMC Syst Biol 9:79
Chang, S Laura; Cavnar, Stephen P; Takayama, Shuichi et al. (2015) Cell, isoform, and environment factors shape gradients and modulate chemotaxis. PLoS One 10:e0123450
Cilfone, Nicholas A; Kirschner, Denise E; Linderman, Jennifer J (2015) Strategies for efficient numerical implementation of hybrid multi-scale agent-based models to describe biological systems. Cell Mol Bioeng 8:119-136
Guzzetta, Giorgio; Ajelli, Marco; Yang, Zhenhua et al. (2015) Effectiveness of contact investigations for tuberculosis control in Arkansas. J Theor Biol 380:238-46
Linderman, Jennifer J; Cilfone, Nicholas A; Pienaar, Elsje et al. (2015) A multi-scale approach to designing therapeutics for tuberculosis. Integr Biol (Camb) 7:591-609

Showing the most recent 10 out of 40 publications